Home > Offer to Sell > Pharmaceuticals and Biochemicals > Antineoplastics agents > Tamoxifen Citrate
Tamoxifen Citrate
Inquiry
| Post Date: | Apr 17,2013 |
| Expiry Date: | Oct 14,2013 |
| Detailed Description: |
Cas No. :54965-24-1
Quantity: 20Metric Tons EINECS: 259-415-2 Assay: 99%-101%. USP31 Packing: 1Kg/foil bag. Delivery: Courier. MF: C32H37NO8 MW: 563.64 Character: White crystalline powder. MP 140-144°C. Usage: For the treatment of advanced, recurrent breast cancer and ovarian cancer and other illnesses. Used as an antineoplastic raw materials. Biological Activity: Estrogen receptor antagonist/partial agonist. Selective and potent inhibitor of mammalian sterol isomerase. Neuroprotective in female rats in vivo . Also high affinity agonist at the membrane estrogen receptor GPR30. |
| CAS Registry Number: | 54965-24-1 |
| Synonyms: | ;(z)-2-[4-(1,2-diphenyl-1-butenyl)phenoxyl]-n,n-dimethyl-ethanamine-citrate;1-p-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene citrate;Tamoxiphen Citrate;2-{4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate (salt); |
| Molecular Formula: | C32H34NO8 |
| Molecular Weight: | 560.6159 |
| Molecular Structure: | 
|
| Hazard Symbols: |  T:Toxic; |
| Risk Codes: | R22:; R45:; |
| Safety Description: | S45:; S53:; |
| Company: | Shenzhen Shijingu Technology Co., Ltd [ China ] |
| Contact: | leihuizhou |
| Tel: | 86-755-89208994 |
| Fax: | 86-755-84556470 |
| Email: | sz10@yccreate.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
